All contents ©2010 ALP Life Sciences, LLC. All rights reserved.
Use of this site signifies acceptance of Terms and Conditions
Use of this site signifies acceptance of Terms and Conditions
Nanoveson™ [Na-no-ves-on]:
The nanobiotechnology triggered action of vesicle (liposome) membrane fusion and aggregation in the intestines; this action facilitates the removal of excess triglyceride deposits from the liver that have been remodeled into bile phospholipids, and sequesters additional inflammatory compounds released from the liver.
The proprietary name of the medical product line being developed by ALP Life Sciences, LLC for the treatment of fatty liver diseases and comorbid inflammatory diseases.